Litcius/Paper detail

Small Extracellular Vesicles From iPSC-Derived Mesenchymal Stem Cells Ameliorate Tendinopathy Pain by Inhibiting Mast Cell Activation

Renzhi Gao, Teng Ye, Zhaochen Zhu, Qing Li, Juntao Zhang, Ji Yuan, Bizeng Zhao, Zongping Xie, Yang Wang

2022Nanomedicine32 citationsDOIOpen Access PDF

Abstract

Aim: This study aimed to explore the effect of small extracellular vesicles from induced pluripotent stem cell-derived mesenchymal stem cells (iMSC-sEVs) on acute pain and investigate the underlying mechanisms. Materials & methods: The pathology of tendons was accessed by hematoxylin and eosin staining, immunohistochemical and immunofluorescent staining. The pain degree was measured by pain-related behaviors. In vitro, we performed β-hexosaminidase release assay, RT-qPCR, toluidine blue staining, ELISA and RNA sequencing. Results: iMSC-sEVs effectively alleviated acute pain in tendinopathy as well as inhibiting activated mast cell infiltration and interactions with nerve fibers in vivo. In vitro, iMSC-sEVs reduced the degranulation of mast cells and the expression of proinflammatory cytokines and genes involved in the HIF-1 signaling pathway. Conclusion: This study demonstrated that iMSC-sEVs relieved tendinopathy-related pain through inhibiting mast cell activation via the HIF-1 signaling pathway.

Topics & Concepts

Mesenchymal stem cellProinflammatory cytokineMast cellTendinopathyMedicineNociceptionStem cellCytokineInflammationPathologyCell biologyBiologyImmunologyInternal medicineTendonReceptorTendon Structure and TreatmentSports injuries and preventionMyofascial pain diagnosis and treatment
Small Extracellular Vesicles From iPSC-Derived Mesenchymal Stem Cells Ameliorate Tendinopathy Pain by Inhibiting Mast Cell Activation | Litcius